Summary Diabetic cardiomyopathy has been associated with a decrease in Na,K-ATPase activity and expression, as well as alterations in membrane lipid composition. The aim of this study was twofold; 1) to document in rats the effect of streptozotocin-induced diabetes on myocardial Na,K-ATPase and fatty acids, and 2) to evaluate the potential effect of a dietary supplementation with fish oil (n-3 fatty acids) on the streptozotocin-induced changes. Assays were performed in purified cardiac plasma membranes to determine Na,K-ATPase activity, expression of the different 
2-isoforms.
Northern blot analysis showed no effect of fish oil supplementation. Experimental diabetes and prevention by the fish oil rich (n-3 fatty acids) diet induced specific effects on the activity and expression of a and that membrane environment may have some effect on insulin sensitivity [19] , insulin-stimulated glucose uptake [20] , and Na,K-ATPase activity [18, 21] .
Membrane environment can also be modified by diet [11] [12] [13] and a number of therapeutic diets are used [22] . Consumption of (n-3) polyunsaturated fatty acids, (e. g. fish oil concentrates) has been reported to lower the risk of cardiovascular disease [23, 24] . Beneficial effects of fish oil (n-3 fatty acids) supplementation include prevention of digitalis toxicity [25] , correction of impaired heart performance in diabetic rats [26] , and prevention of fatal ventricular fibrillation induced by ischaemia [27, 28] .
In previous work, we demonstrated that the properties of Na,K-ATPase isoenzymes in the rat brain could be modified by administration of dietary fatty acids [12] and, in particular, by fish oil supplementation [13] . These effects have been attributed to changes in the fatty acid content of plasma membranes.
The aims of this study were twofold. We first documented the effect of streptozotocin (STZ)-induced diabetes on fatty acid composition and Na,K-ATPase activity in cardiac muscle membranes. Ouabain affinity and subunit expression were also assessed. We then evaluated the potential effect of a fish oil rich (n-3 fatty acids) diet on these STZ-induced changes.
Materials and methods
Animals. Four-week-old male Sprague-Dawley (n = 30) rats weighing approximately 200 g were randomly divided into three groups of 10. In two groups, diabetes was induced by intravenous injection of streptozotocin (STZ) at 60 mg/kg (STZ; Sigma, L'Isle d'Abeau, Chesne, France) diluted immediately before injection in citric acid buffer (0.01 mol/l, pH 5.5). In the control group only citric acid buffer was injected. One group of diabetic animals (DM) was fed the standard rat chow diet supplemented with (n-3) fatty acid-enriched fish oil concentrate (MaxEPA, Pierre Fabre Santé , Castres, France) administered over 8 weeks at a daily dose of 0.5 g/kg by gavage. This dose has previously been shown to affect cardiac function of n-3 fatty acid treated diabetic animals [26] . This supplement is rich in eicosapentaenoic acid (EPA, C20:5 (n-3)) and docosahexenoic acid (DHA, C22:6 (n-3)). The other group of diabetic animals (DO) was fed the standard rat chow diet supplemented with olive oil. Diabetic rats were not treated with insulin. The non-diabetic control group (CO) was also fed the standard rat chow diet supplemented with olive oil. Olive oil was chosen as the placebo because it does not contain (n-3) fatty acids. Water was given ad libitum to all groups. All animal treatments adhered strictly to all institutional and national ethical guidelines.
Blood samples were collected regularly from the tip of the tail, and blood glucose was measured with a reagent strip (Reflolux, Boehringer Mannheim, Mannheim, Germany).
Eighteen (6 per group) of the 30 animals were killed by decapitation after 8 weeks. On the day of killing, blood samples were taken for determination of glucose, cholesterol, triglyceride, HDL-cholesterol, and insulin using the following standard plasma test kits (Boehringer Mannheim): peridochrome glucose method; chod PAP cholesterol method; GPO-PAP triglyceride method; HDL-cholesterol method; and INSIK 5 insulin method (Sorin Biomedica, Salugga, Italy) using a standard of rat insulin (Novo, Copenhagen, Denmark).
Tissue preparations. Hearts were rapidly removed, rinsed with ice-cold saline in less than 30 s, frozen in liquid nitrogen, and stored at -80°C until use. Frozen pieces of ventricle (200 mg) were homogenized directly in 10 volumes of ice cold buffer containing 20 mmol/l sodium pyrophosphate, 0.1 mmol/l phenylmethane sulfonyl fluoride, 1 mmol/l EDTA, 250 mmol/l sucrose, 80 mmol/l KCl, and 20 mmol/l imidazol/HCl (pH 7.4 at 25°C) with a polytron PT20 (15 s; setting 5) [29] . The homogenate was subfractionated by two sequential differential centrifugations at 7000 × g for 15 min and 46000 × g for 30 min using a TLA-100.3 rotor Beckman, in the Beckman TL-100 Tabletop ultracentrifuge (Gagny, France). The pellet was resuspended in 100 mmol/l NaCl, 250 mmol/l sucrose, and 30 mmol/l imidazol/HCl (pH 7.4 at 25°C) and stored frozen in liquid nitrogen. Protein yields were consistently 1.9 %, 2 % and 2 % for animals in the CO, DO, and DM groups, respectively.
Enzymology study. Na,K-ATPase activity was determined by coupled assays at 37°C with or without ouabain as previously described [30] . Assays were carried out with either native vesicles or opened vesicles treated with unmasking agents. The vesicle orientation of our membrane preparations was defined by detergent treatment performed with three SDS concentrations (0.1, 0.2 and 0.3 mg SDS/mg protein for 30 min at 20°C). This information was important since the Na,K-ATPase activity of native membranes depends on the proportion of permeable (leaky) vesicles in which ouabain and ATP have free access to their sites of action. SDS treatment revealed latent ouabain sensitive activity in impermeable right-side-out and inside-out vesicles with ATP sites on the intravesicular and extravesicular sides, respectively.
The relative proportion of a 1 and a 2 isoenzymes was inferred from ouabain affinities, as estimated from dose-response curves on permeabilized membranes with the highest Na,K-ATPase activity (0.1 mg SDS/mg protein ) [31] . Curves were fit to experimental data by a non-linear regression model [30] using MKModel software (Biosoft, Cambridge, UK). The number of independent sites used to model the data was chosen according to the Schwartz criterion [32] .
SDS-PAGE and Western blots.
Three microsomal preparations representative of the enzymological study were diluted in 3 volumes of denaturation buffer containing 0.5 mol/l Tris-HCl pH 6.8, 0.1 % glycerol, 10 % SDS, and 1 % bromophenol blue supplemented with 1 % b -mercaptoethanol. Electrophoresis was carried out with a Miniprotean II Cell Apparatus by SDS-PAGE on 4-15 % gradient ready gels (Bio-Rad, Ivry sur Seine, France) for 90 min at 100 volts. Proteins were then transferred to nitrocellulose (Hybond, Amersham, Les Ulis, France) in a transfer buffer containing 192 mmol/l glycine, 24 mmol/l Tris, 0.1 % SDS, and 10 % methanol at 4°C for 60 min at 200 mA constant current. After incubation in phosphate buffered saline (PBS) (80 mmol/l Na 2 HPO 4 , 20 mmol/l NaH 2 PO 4 , and 100 mmol/l NaCl, pH 7.5, supplemented with 3 % low-fat milk) over night at 4°C to minimize non-specific binding. The resulting nitrocellulose blots were probed for 60 min at 37°C with antibodies specific for the various Na,KATPase isoenzymes. A site-directed rabbit polyclonal antibody specific for rat 1 isoenzyme. These blots were exposed to Xray film (Hyperfilm ECL, Amersham, les Ulis, France) for various times to ensure that chemiluminescent signals were within the linear range of the film. Samples from the three groups were always loaded on the same gel and transferred to the same blot for quantitative densitometry. At least three independent blots were analysed with reproducible results.
The resulting blots were scanned with a AGFA ARCUS densitometer (Agfa-Gevaert AG, Morbel, Belgium) in transparency mode at a resolution of 150 pixels per inch (ppi). The scans were processed on a Macintosh II running the public domain software, Image, written by Wayne Rasband at the Bethesda, Md., USA.
Total phospholipid fatty acid composition of various membrane fractions. Fatty acids were analysed as methyl esters on a Varian model 3300 gas chromatograph (Varian, les Ulis, France) equipped with a flame ionization detector using a spirawax capillary column (25 m × 0.2 mm internal diameter). The temperature program was 150 to 210°C at 1.5°C/min. Peak areas from the resulting chromatogram were measured with a Merck model D 2000 integrator (Merck, Nogent, France). After extraction of free acids according to the method of Folch et al. [33] , fatty acid methyl esters were prepared according to Hagenfeld [34] . Nonadecanoic acid (C19:0) was added to the mixture before methylation as an internal standard.
Northern blot analysis. Total RNA was prepared from the same frozen cardiac ventricles used for Western blot analysis using the acid isothiocyanate-phenol-chloroform procedure [35] . Northern blot analysis was performed essentially as described by Ouafik et al. [36] . Briefly, RNA (20 m g/lane) was resolved by electrophoresis on 1 % agarose formaldehyde denaturing gels. The denaturd RNAs were transferred to Hybond-N membrane, cross-linked by ultra-violet irradiation, hybridized to 1 cDNA (gift of P. MartinVasallo, Universidad de la laguna, Tenerife, Spain). Filters were prehybridized, hybridized, and washed as previously described [36] . To correct for the actual amount of RNA in each lane, blots were stripped and hybridized to S26 cDNA probes [37] . The quantification was performed using the National Institutes of Health Image 1.54 Software (NIH, Bethesda, Md., USA).
Statistical analysis
Differences between the three groups (CO, DO and DM) were evaluated by one-way analysis of variance (ANOVA) followed by multiple comparisons with Scheffé tests using Statview software. Values of p less than 0.05 were considered statistically significant.
Results
General features of control and diabetic rats. Table 1 shows various indices of metabolic status measured after 8 weeks of STZ-induced diabetes in control animals (CO), diabetic animals fed olive oils (DO), or fish oils (DM). Both DO and DM animals presented severe hyperglycaemia, hypoinsulinaemia and hypercholesterolaemia relative to CO animals. In contrast, there were no differences in plasma HDL-cholesterol levels between control, diabetic, and fish oil treated diabetic rats. Daily supplementation with fish oil (n-3 fatty acids) at 0.5 g/kg had no effect on the plasma modifications induced by diabetes.
The mean body and heart weights were decreased by diabetes as compared to control animals. The heart-to-body weight ratios were respectively 1.2 and 1.3 times greater in DO and DM animals. Table 2 compares ouabaininsensitive (Mg-ATPase) and sensitive (Na,K-ATPase) ATPase activity in native microsomal vesicles from control animals and, diabetic animals fed olive or fish oils. Mg-ATPase and Na,K-ATPase activities were significantly lower in diabetic rats than control rats. Dietary fish oil (n-3 fatty acids) supplementation had no effect on Na,K-ATPase activity when measurements were made in native membranes. To reveal the full activity, we performed a detergent treatment at doses of 0.1, 0.2 and 0.3 mg SDS. This procedure demonstrated that the optimal dose was 0.1 mg SDS/ mg protein (data not shown). When treated with SDS, Na,K-ATPase, but not Mg-ATPase, was significantly lower in diabetic rats than in control rats (Table 2). Furthermore, the Na,K-ATPase activity in DM rats appeared significantly more decreased than in DO rats ( Table 2) . Insulin (ng/ml) 2.6 ± 1. Detergent treatment at different SDS concentrations also allowed us to determine the orientation of the vesicles and to confirm the absence of right-sideout vesicles in the three groups of membrane preparations (data not shown). The comparison of ouabain-sensitive and -insensitive activities in native and detergent-treated membranes allowed estimation of the relative proportions of leaky and inside-out vesicles in the different groups, i. e. 46 ± 3 % (ratio of 14.7/31.7) and 54 ± 5 %, respectively in CO; 43 ± 4 % (ratio of 9.9/23.1) and 57 ± 5 % respectively in DO; and 62 ± 3 % (ratio of 8.7/14) and 38 ± 3 % respectively in DM ( Table 2 ). The proportion of leaky membranes was increased in the DM group as compared to that observed in the DO and CO groups.
Na,K-ATPase activities.
Ouabain sensitivity. Isoforms of Na,K-ATPase in the rat are known to exhibit different affinities for ouabain [11] . Na,K-ATPase activity in detergent-treated membranes was assayed at different concentrations of ouabain to estimate the proportion of the two cardiac isoenzymes in the three study groups. Two isoenzymes were assumed to be present because the doseresponse curves presented in Figure 1 were biphasic and best modelled assuming two, rather than one, affinity constants according to the Schwartz criterion (Materials and methods).
Diabetes induced no significant changes in the affinity and contribution of the low affinity ouabain binding sites (Table 2 ). In contrast the ouabain affinity for the high affinity sites in the DO group was significantly lower than in the CO group.
Fish oil (n-3 fatty acids) supplementation induced marked changes in the contribution of low and high affinity ouabain sites in diabetic rats. The contribution of high affinity sites increased from 1/10 to 1/3. Ouabain affinity for the low affinity sites in the DM group was significantly (p < 0.05) higher than in the DO group. No significant difference in ouabain affinity was observed for the high affinity sites. Table 2 lowered low affinity site activity and increased high affinity site activity in SDS-treated vesicles similar to that of controls (Table 2) . 
Fatty acid composition of cardiac membranes.
The composition of fatty acids in total phospholipid from cardiac membranes was clearly different between diabetic (DO) and control (CO) rats (Table 3) .
Incorporation of two polyunsaturated fatty acids (PUFA), linoleic acid [C18:2(n-6)] and C20:3(n-6), was significantly (p < 0.05) increased in the membranes from diabetic rats. Since no difference in the total PUFA content of the (n-6) series was observed, the marked parallel decrease (-53 %) in arachidonic acid [C20:4(n-6)] compensated for the marked increase ( + 40 %) in linoleic acid and in C20:3(n-6). The explanation may be an impaired utilization of linoleate and of C20:3(n-6) resulting from inhibition of D 6-and D 5-desaturase activity, respectively in the diabetic membranes. The opposite effects on membrane content of two monounsaturated fatty acids (MUFA) from two different series, (n-9) and (n-7), the increase in oleic acid [C18:1(n-9)], and the decrease in C18:1(n-7) could also have resulted from diminished D 6-desaturase activity. The fatty acid content of the (n-3) series and the total amount of PUFA, saturated fatty acid (SFA), and MUFA, as well as the (n-6/n-3) molar ratio, were not affected by diabetes. Table 3 (columns DO and DM) also shows the effects of fish oil supplementation on the fatty acid content of membranes from diabetic rats. The content of C20:5(n-3) (EPA) increased twofold without modification of PUFA, MUFA, and SFA contents or the (n-6/n-3) molar ratio. The amount of eicosanoid acids (C20:4 and C20:5) remained lower in both diabetic groups than in controls. Despite the fish oil (n-3 fatty acids) supplementation, the content of C22:6(n-3) (DHA) was not increased in the DM as compared to the DO group.
Northern blot analysis.
To determine whether the changes in Na,K-ATPase activity and (Fig. 6 and 7 ).
Discussion
In this study, we measured diabetes-induced abnormalities in Na,K-ATPase activity, isoenzyme expression, and fatty acid content in heart membranes. We also assessed the preventive effects of dietary fish oil supplements (n-3 fatty acids, MaxEPA) on these abnormalities. Na,K-ATPase activity in cardiac membranes of adult rats decreased with diabetes, as did the relative abundance of the a 2 and b 1 isoforms (both mRNA and protein levels). In contrast, the abundance of the a 1 isoforms increased in diabetic animals. The fact that a 1-isoenzyme expression does not fully account for the decrease in enzyme activity suggests that alterations in the membrane environment may also play a role. Fish oil supplementation changed the fatty acid content of myocardial membranes and prevented the diabetesinduced altered activity and/or restored the activity of the a 2 isoenzyme without changing its expression. Fish oil supplementation did not modify the native membrane Na,K-ATPase activity. However, alterations of membrane environment by SDS treatment showed a further decrease in the activity of the Values represent the relative amounts, expressed as a percentage of the total identified fatty acids by weight. Values are means ± SD of six animals. Values in the same lane not bearing the same superscript letters were significantly different at p < 0.05 ND, Not detectable membranes could be partly responsible for these observations. We chose to study enzymatic activity, protein and mRNA expression, and fatty acid content in the membrane of diabetic rat hearts for several reasons. The first is that although diabetes has been shown to be associated with an impairment in essential fatty acid metabolism [38] [39] [40] , accurate information about changes in isoenzyme activity, subunit expression and the relative importance of the lipid environment in diabetes-induced sarcolemmal alterations is lacking. Second, previous dietary experiments demonstrated the dependence of the activity and ouabain affinity of isoenzymes on membrane fatty acid content [12, 13] , which influences membrane structure and function in brain. The third reason for our study is the clinical relevance of the experimental model and its utility in the evaluation of dietary influence. The impaired systolic and diastolic function observed in diabetic rats [41] [42] [43] is similar to the one used to prove the presence of cardiomyopathy in diabetic patients. We used a dose of MaxEPA (0.5 g ⋅ kg -1 ⋅ day) that affects cardiac function of n-3 fatty acid treated diabetic animals [26] and corresponds to a daily dosage of 90 mg EPA, equivalent to 6.3 g in a human with a body weight of 70 kg. Most clinical trials have been conducted using varying daily doses of fish oil from 1.5 to 6.7 g EPA [44] . A limitation is that the dose calculations comparing the rat and human doses are not very accurate since they are based on body weight. Indeed, lipid metabolism is more closely related to surface area than to weight.
The diabetic rats gained much less body weight than control rats. Heart weight and heart-to bodyweight ratios were also significantly lower in diabetic rats. Without documentation of myocyte enlargement, histological data, and isozyme shifts, however, we cannot infer the presence of a cardiac hypertrophy in the diabetic rats. Furthermore, these changes in ratios, although significant, are too limited ( + 20 %), and they could simply result from a large body weight loss. It follows that cardiac hypertrophy may or may not explain the observed changes in Na,K-ATPase.
In this study, we found that diabetes induced a significant decrease of 33 and 26 % in Na,K-ATPase and Mg-ATPase activities, respectively. The reduction in Na,K-ATPase activity was consistent with the results of a previous study using the same experimental model with a different enzymatic assay, i. e. measurement of K-stimulated pNPPase, which is a partial reaction of the Na,K-ATPase enzymatic cycle [9] . The observation of a decreased Mg-ATPase activity in native vesicles could be related to the sensitivity of enzyme activity to lipid environments. The fact that detergent treatment with SDS diminished the reduction in MgATPase activity only indicates that this activity is sensitive to membrane and/or protein-lipid interaction Foussard-Gilbert et al. [45] demonstrated the importance of changes induced in the membrane protein environment by detergent treatment. SDS treatment at multiple concentrations from 0.1 to 0.3 mg SDS/ mg protein also allowed us to conclude that diabetes did not affect the relative proportion of the different vesicles in these membrane preparations.
To correlate the reduced Na,K-ATPase activity to isoenzyme activity, we plotted ouabain dose-response curves. We observed that the Na,K-ATPase activity of the a 1-isoenzyme decreased by 26 % while that of the a 2-isoenzyme decreased by 43 % ( Table 2 ). The fact that both isoenzymes were affected could be due to an alteration in enzyme kinetics, protein subunit expression, or both. To answer this question, we assayed the pattern of isoenzyme expression and analysed the fatty acid content of cardiac membranes in parallel as previously described [12, 13] .
Altered lipid environment and protein expression were the most likely explanations for the decrease in Na,K-ATPase activity observed in cardiac membranes in the present study. The two isoenzymes appear to be specifically affected by these two parameters. Ng et al. [9] studied changes caused by STZ-induced diabetes on expression of cardiac Na,K-ATPase subunit isoforms and reported that a 2 and b 1 protein expression decreased while a 1 protein expression remained unchanged. The Northern blot analysis confirms these results on protein expression. The decrease of a 2 protein expression was consistent with the lower levels of isoenzyme activity and density that were detected. In contrast, our findings indicate that a 1 protein abundance increased. This increase did not correlate with the activity inhibitable by high ouabain concentrations (Table 2) . We could reasonably speculate that some a 1-isoenzyme was not assembled with b 1 into functional enzyme units since b 1 levels were decreased by diabetes, and this could be a limiting factor for full activity [46, 47] . Indeed, the stoichiometry could be affected by diabetes [48] . Furthermore, the lower activity of the Na,K-ATPase induced by diabetes could result from different enzymatic rates [49] or phosphorylation status [50] .
The diabetes-induced alterations in total fatty acid content observed in this study may result from both (Table 3) because substrates of these enzymes were increased, C18:1 (n-9) (oleic acid), C18:2(n-6) (linoleic acid), and C20:3(n-6) and the final product of the reaction was decreased, C20:4(n-6) (arachidonic acid). Such an inhibition of D 6 and D 5-desaturases [40, 51] has been attributed either to the glucose-rich medium and/or insulin deficiency [52] . These alterations in the lipid environment are comparable to those previously described in membranes from STZ-treated rats and erythrocytes of diabetic patients [18, 38, 40] . Other factors not investigated in this study such as membrane fluidity or the phospholipid profile could also participate in the enzyme-linked membrane changes [40] .
One may speculate that the reduced activity of both isoenzymes impairs myocyte contractility and plays a role in the development of diabetic cardiomyopathy [7, 53] . Indeed it seems reasonable to assume that intracellular Na + and K + homeostasis is altered, given the recent evidence for differences in the affinities of isoforms for Na + [30] . The second purpose of this study was to assess the ability of fish oil supplementation (n-3 fatty acids) to prevent diabetes-induced changes. The potential effects of fish oil could be to prevent the onset or to delay the progression of the disease. Supplementation had no effect on plasma characteristics or on heart and body weight (Table 1 ).
In the enzymological study, Na,K-ATPase activities (native membranes) measured in the fish oil supplemented diabetic group were the same as the olive oil supplemented diabetic group (Table 2) . However, in SDS-treated membranes, Na,K-ATPase was markedly lower in the fish oil supplemented diabetic group relative to either the olive oil supplemented diabetic group or the control group. This suggests that fishoil-supplementation changes the orientation of vesicles during the membrane preparation. The proportion of inside-out vesicles was lower in the fish oil supplemented groups.
The modification of the relative proportion of a 1-and a 2-isoenzymes could explain the opposite effects of fish oil supplementation, i. e. a large decrease in a 1-isoenzyme activity and a prevention and/or restoration of a 2-isoenzyme activity (Table 2 ). These effects were achieved without a change in protein and RNA abundances as compared to the olive oil supplemented diabetic group. In the fish oil supplemented diabetic group, the ouabain affinity for the a 2-isoenzyme was the same as in the olive oil supplemented diabetic group whereas that of the a 1-isoenzyme was higher. Such changes in ouabain affinity have already been described as a result of fatty acid membrane changes [54] .
The increase in b 1 polypeptide levels is not related to changes in its mRNA expression, since its mRNA abundance was not modified after fish oil diet. This result is in favour of a post-transcriptional regulation of the b 1 subunit by fish oil. For a 2-isoenzymes, the mechanism underlying a restored activity without a change in expression could be: 1) an increased turnover of a 2-isoenzymes via covalent modification (e. g. phosphorylation processes) [49] or by an increase in membrane fluidity with incorporation of EPA; or 2) an increase in active a 2b1 complexes produced by the elevated abundance of b 1. The large increase in the membrane incorporation of EPA ( + 50 %) and its consequences (as a structural component of tissue lipids or precursors of prostaglandins) could modify the membrane lipid environment of Na,K-ATPase isoenzyme, and explain vesicle orientation, restoration of a 2-isoenzyme activity, and a1-isoenzyme ouabain affinity, as well as increased b 1 levels. These studies suggest that fish oil therapy may be effective in preventing or treating some of the adverse consequences of diabetes.
